Areas of Expertise

iBET works in a broad range of fields that encompass multidisciplinary approaches ranging from basic, technological to clinical and translational research, from the development of complex biopharmaceuticals and novel therapies to areas in food and health, including nutraceuticals development and agro-forestry.

R&D Services

Innovation

Biopharma

Innovation

Food & Nutraceuticals

Innovation

Emerging Areas
Work with us

Who we are

Our team, vision and mission

Latest News

Our most recent news and accomplishments
24.02.2022

Thursday

Joana Almeida Awarded Best Poster Presentation at ECI Conference on Advancing Manufacture of Cell and Gene Therapy
News
Exploring the human microbiome to mature hiPSC- derived hepatocytes
04.02.2022

Friday

GenIbet acquired by Swedish CDMO Recipharm
News
Internationalization of iBET’s spin-off specialized in Biologics for clinical trials
31.01.2022

Monday

Catarina Brito was an invited speaker at the 3D Cell Culture Workshop by ICT Mumbai
News
Artificial organs/tissues for regenerative medicine

Conferences

24.01.2022

Monday

Giacomo Domenici presents 3D Cell Model of Ewing’s Sarcoma at EuSARC 2022 Lectures
News
European Network for Sarcoma Online Lecture Series
Filter your search by

Definições de Cookies

O iBET pode utilizar cookies para memorizar os seus dados de início de sessão, recolher estatísticas para otimizar a funcionalidade do site e para realizar ações de marketing com base nos seus interesses.

Permitem personalizar as ofertas comerciais que lhe são apresentadas, direcionando-as para os seus interesses. Podem ser cookies próprios ou de terceiros. Alertamos que, mesmo não aceitando estes cookies, irá receber ofertas comerciais, mas sem corresponderem às suas preferências.
Oferecem uma experiência mais personalizada e completa, permitem guardar preferências, mostrar-lhe conteúdos relevantes para o seu gosto e enviar-lhe os alertas que tenha solicitado.
Permitem-lhe estar em contacto com a sua rede social, partilhar conteúdos, enviar e divulgar comentários.